IFNA1 and systemic lupus erythematosus: However, the term has been extended to non-Mendelian autoimmune diseases such as dermatomyositis, systemic sclerosis, and systemic lupus erythematosus (SLE), as well as more rare diseases such as Degos disease, where IFN signaling is important to pathogenesis (5–7).